China’s Creat Group Corp, one of the country’s large investors in foreign companies, is purchasing Germany’s Biotest AG, a Frankfurt Stock Exchange-listed biologics company, for about €1.2 billion. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
